Zura Bio (ZURA) Competitors $2.90 -0.25 (-7.94%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZURA vs. TYRA, RAPP, RLAY, ERAS, AUTL, EOLS, PLRX, CRON, CGEM, and PRTAShould you be buying Zura Bio stock or one of its competitors? The main competitors of Zura Bio include Tyra Biosciences (TYRA), Rapport Therapeutics (RAPP), Relay Therapeutics (RLAY), Erasca (ERAS), Autolus Therapeutics (AUTL), Evolus (EOLS), Pliant Therapeutics (PLRX), Cronos Group (CRON), Cullinan Therapeutics (CGEM), and Prothena (PRTA). These companies are all part of the "pharmaceutical products" industry. Zura Bio vs. Tyra Biosciences Rapport Therapeutics Relay Therapeutics Erasca Autolus Therapeutics Evolus Pliant Therapeutics Cronos Group Cullinan Therapeutics Prothena Tyra Biosciences (NASDAQ:TYRA) and Zura Bio (NASDAQ:ZURA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership. Do institutionals & insiders hold more shares of TYRA or ZURA? 84.1% of Tyra Biosciences shares are owned by institutional investors. Comparatively, 61.1% of Zura Bio shares are owned by institutional investors. 15.4% of Tyra Biosciences shares are owned by insiders. Comparatively, 22.1% of Zura Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media refer more to TYRA or ZURA? In the previous week, Tyra Biosciences and Tyra Biosciences both had 6 articles in the media. Zura Bio's average media sentiment score of 0.47 beat Tyra Biosciences' score of 0.19 indicating that Zura Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tyra Biosciences 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zura Bio 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings & valuation, TYRA or ZURA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTyra BiosciencesN/AN/A-$69.13M-$1.61-9.86Zura BioN/AN/A-$69.24MN/AN/A Which has more risk & volatility, TYRA or ZURA? Tyra Biosciences has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Zura Bio has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500. Do analysts rate TYRA or ZURA? Tyra Biosciences currently has a consensus price target of $31.00, suggesting a potential upside of 95.34%. Zura Bio has a consensus price target of $15.80, suggesting a potential upside of 444.83%. Given Zura Bio's higher possible upside, analysts clearly believe Zura Bio is more favorable than Tyra Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Zura Bio 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is TYRA or ZURA more profitable? Tyra Biosciences' return on equity of -24.56% beat Zura Bio's return on equity.Company Net Margins Return on Equity Return on Assets Tyra BiosciencesN/A -24.56% -23.31% Zura Bio N/A -37.36%-29.81% Does the MarketBeat Community believe in TYRA or ZURA? Tyra Biosciences received 13 more outperform votes than Zura Bio when rated by MarketBeat users. However, 81.82% of users gave Zura Bio an outperform vote while only 73.81% of users gave Tyra Biosciences an outperform vote. CompanyUnderperformOutperformTyra BiosciencesOutperform Votes3173.81% Underperform Votes1126.19% Zura BioOutperform Votes1881.82% Underperform Votes418.18% SummaryTyra Biosciences beats Zura Bio on 6 of the 11 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZURA vs. The Competition Export to ExcelMetricZura BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$189.34M$2.93B$5.06B$8.82BDividend YieldN/A1.89%5.18%4.07%P/E RatioN/A45.61126.3117.81Price / SalesN/A360.261,178.7474.57Price / CashN/A160.0933.8632.53Price / Book1.573.734.684.68Net Income-$69.24M-$41.63M$119.54M$226.08M7 Day Performance-19.44%-4.73%-1.83%-1.04%1 Month Performance-39.96%-6.53%-3.60%1.04%1 Year Performance-34.98%25.63%31.91%26.28% Zura Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZURAZura Bio3.9055 of 5 stars$2.90-7.9%$15.80+444.8%-35.1%$205.68MN/A0.003Analyst ForecastTYRATyra Biosciences3.0757 of 5 stars$15.87-2.1%$31.00+95.3%+40.8%$820.27MN/A0.0020RAPPRapport Therapeutics1.8437 of 5 stars$22.19-0.4%$35.00+57.7%N/A$814.92MN/A0.00N/ANews CoverageRLAYRelay Therapeutics3.2712 of 5 stars$4.66-2.9%$21.22+355.4%-44.5%$803.44M$25.55M0.00304Gap DownHigh Trading VolumeERASErasca2.8027 of 5 stars$2.64-5.4%$6.08+130.4%+17.3%$788.81MN/A0.00126Analyst ForecastAnalyst RevisionAUTLAutolus Therapeutics3.4682 of 5 stars$2.80-5.1%$10.15+262.5%-36.5%$784.98M$1.70M0.00330Analyst UpgradeEOLSEvolus4.0221 of 5 stars$12.63+1.9%$23.00+82.1%+28.4%$784.55M$202.09M0.00170Positive NewsPLRXPliant Therapeutics3.4847 of 5 stars$12.73-0.5%$40.57+218.7%-11.4%$778.32M$1.58M0.0090CRONCronos Group1.7856 of 5 stars$2.01-1.0%$3.00+49.3%-3.8%$776.06M$87.24M-15.46356CGEMCullinan Therapeutics1.8429 of 5 stars$12.58-4.0%$31.67+151.7%+43.6%$762.78M$18.94M0.0030Analyst RevisionPRTAProthena1.6436 of 5 stars$14.40+2.5%$61.86+329.6%-57.8%$756.01M$91.37M0.00173Analyst DowngradeAnalyst Revision Related Companies and Tools Related Companies TYRA Alternatives RAPP Alternatives RLAY Alternatives ERAS Alternatives AUTL Alternatives EOLS Alternatives PLRX Alternatives CRON Alternatives CGEM Alternatives PRTA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZURA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
